Correlation between APRI Index, MELD Score and Child Pugh Score in cirrhosis of liver


  • B. C. Prakash Department of General Medicine, Bangalore Medical College and Research Institute, KR Fort, Bangalore, Karnataka, India
  • Abhiman Shetty B. Department of General Medicine, Bangalore Medical College and Research Institute, KR Fort, Bangalore, Karnataka, India



Aspartate amino transferase to platelet ratio index, Child Pugh score, Cirrhosis of liver, Model for end-stage liver disease


Background: Liver cirrhosis is the end result of chronic liver injury and is one of the most common cause of morbidity and mortality. Several scorings are available to predict the severity and prognosis of liver cirrhosis. This study aims to calculate APRI index, MELD score and child Pugh score in cirrhosis patients and to find the correlation between them.

Methods: This is the Cross-sectional study on 100 patients confirmed with cirrhosis of liver. Cirrhosis due to alcohol, Hepatitis B and C, autoimmune, Cryptogenic, NAFLD, were included in the study. APRI Index, MELD Score and Child Pugh Score were calculated, and the correlation was obtained.

Results: This study found out the relationship between APRI index, MELD Score and Child Pugh Score with significant p value. The study also showed that all the three scores were raised with patients who had complication of cirrhosis like encephalopathy, refractory ascites. Among those who had complication like grade 3 or 4 encephalopathy, APRI index had a mean value of 3.4, Child Pugh had a mean score of 13.2, and MELD had a mean score of 36.08 with standard deviation of 2.0, 1.5, 6.0 respectively.

Conclusions: APRI index is an independent predictor of morbidity and mortality. The prognostic performance of all 3 was comparable, Hence APRI index can be used as an alternative scoring which is cost effective and objective method in predicting the severity and prognosis in cirrhosis of liver.


Dooley JS, Burroughs AK, Heathcote EJ. Sherlock’s disease of liver and biliary system, 12th edition, chapter 7-Hepatic cirrhosis; 2011:103.

Schiff ER, Maddrey WC, Reddy KR. Schiff’s disease of liver, 11th Ed, Hepatic fibrosis; 2017:297-311.

Garcia-Tsao G, Lim J. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009 Jul;104(7):1802.

Mark E Mailliard, Micheal F Sorell. Alcoholic Liver Disease. Harrison’s Principles of Internal Medicine. 19th ed. New York. McGraw Hill; 2015:2052.

Kumar V, Abbas A, Aster J. Robbins textbook of basic pathology, 8th Ed; 2012:633-639.

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749-61.

Kamath PS, Kim WR. The model for end‐stage liver disease (MELD). Hepatol. 2007 Mar;45(3):797-805.

Chung GE, Lee JH, Kim YJ. Does antiviral therapy reduce complications of cirrhosis?. World J Gastroenterol: WJG. 2014 Jun 21;20(23):7306.

Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol. 2003 Aug 1;38(2):518-26.

Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006 Jul;101(7):1500.

Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, Harrisons Principals of Internal Medicine. 20th Ed. 1995:357-354.

Toghill PJ, Green SH, Ferguson F. Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol. 1977 Apr 1;30(4):367-71.

Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of. J Clin Invest. 1966 May 1;45(5):645-57.

Nalpas B, Vassault A, Guillou AL, Lesgourgues B, Ferry N, Lacour B, et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatol. 1984 Sep;4(5):893-6.

Kamimoto Y, Horiuchi S, Tanase S, Morino Y. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatol. 1985 May;5(3):367-75.

Wong S, Huynh D, Zhang F, Nguyen NQ. Use of aspartate aminotransferase to platelet ratio (APRI) to reduce the need for Fibro Scan in the evaluation of liver fibrosis. World J Hepatol. 2017 Jun 18;9(17):791.






Original Research Articles